Oxford Nanopore Technologies PLC
LSE:ONT
Relative Value
The Relative Value of one ONT stock under the Base Case scenario is 198.441 GBX. Compared to the current market price of 99.337 GBX, Oxford Nanopore Technologies PLC is Undervalued by 50%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ONT Competitors Multiples
Oxford Nanopore Technologies PLC Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
UK |
Oxford Nanopore Technologies PLC
LSE:ONT
|
853.5m GBP | 5 | -5.5 | -4.9 | -3.7 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 5.2 | 37 | 22.8 | 33.5 | ||
US |
Danaher Corp
NYSE:DHR
|
182.6B USD | 4.2 | 22.6 | 16.5 | 20.3 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
42.6B USD | 2.8 | 31.4 | 17 | 26.2 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.8B CHF | 5.6 | 57.9 | 19.9 | 29.1 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.4B USD | 6 | 32.7 | 26.1 | 31.4 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64.1 | 33.8 | 48.6 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 7 | 33.8 | 23.6 | 26.3 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.5B USD | 9 | 44.6 | 30.5 | 36.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.4B USD | 3.1 | 41.5 | 17.6 | 27.5 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.5B EUR | 7.2 | 76.4 | 32.8 | 53.9 |